Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Vitamin D Supplementation in Combination With Azithromycin and Topical Retinoid for Acne: A Randomized Controlled Trial

ID
Name
Vit-D
Description
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is: • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone. Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid. Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.
Trial arms
Trial start
2023-12-01
Estimated PCD
2024-03-01
Trial end
2024-03-01
Status
Not yet recruiting
Treatment
D Max Drops
Vitamin D
Arms:
Vitamin D
Azithromycin 250 milligram Oral Capsule
Anti Biotic
Arms:
Placebo, Vitamin D
Adapalene
Retinoid
Arms:
Placebo, Vitamin D
Size
58
Primary endpoint
Efficacious
2 months
Eligibility criteria
Inclusion Criteria: * Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included. Exclusion Criteria: * Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs) * Those with obesity * Individuals employing vitamin supplementation * Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 58, 'type': 'ESTIMATED'}}
Updated at
2023-11-21

1 organization

2 products

1 indication

Organization
HITEC Institute of Medical Sciences
Product
Azithromycin
Indication
Acne Vulgaris
Product
Adapalene